Blog - UPRA | Ukrainian Psychedelic Research Association | психоделічно асистована терапія | ПАТ | Ukraine

Skip to main content

PTSD Catches Up Not Only in Dreams: Can Ukraine Lead the Psychedelic Revolution in Medicine?

28 June 2025 | Переглянуто: 1214

Ukraine's first training project on MDMA-assisted psychotherapy with the support of MAPS is completed

13 May 2025 | Переглянуто: 485

Memorandum between UPRA and CO CF "TECHNO4"

23 April 2025 | Переглянуто: 530

2024: UPRA in achievements and figures

05 April 2025 | Переглянуто: 714

The Ministry of Health of Ukraine published a draft resolution

24 March 2025 | Переглянуто: 334

2C-B: The Forgotten Psychedelic That Could Be a Game-Changer

14 January 2025 | Переглянуто: 3919

The topic of psychedelics in the structure of the educational process

08 January 2025 | Переглянуто: 370

Magic mushrooms and personal safety: scientific protocols for the use of psilocybin-containing substances

24 November 2024 | Переглянуто: 1773

Legal issues of introducing ketamine-assisted therapy in Ukraine

22 November 2024 | Переглянуто: 475

MDMA as medicine after the Israeli-Palestinian war

20 November 2024 | Переглянуто: 691

From Drugs to Medicine: How the U.S. Changed Its Perception of Psychedelics Over Half a Century

30 August 2024 | Переглянуто: 625

Psychedelic-assisted therapy

21 August 2024 | Переглянуто: 615

FDA Rejects Lykos’ Drug Application and Requests an Additional Phase 3 Clinical Trial

14 August 2024 | Переглянуто: 307

Post-traumatic stress disorder (PTSD)

11 August 2024 | Переглянуто: 166

Why Did the FDA's Advisory Committee Recommend Rejecting MDMA as a PTSD Treatment and What Does This Mean for Ukraine?

04 July 2024 | Переглянуто: 1553